Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes.

To evaluate the importance of the raised levels of growth hormone that characterize poor diabetic control, we gave growth hormone for 21 to 45 hours in the form of hourly 100-micrograms pulses to 14 diabetics being treated by insulin pump. Insulin-pump settings and meals were kept constant. Mean 24-hour levels of growth hormone (+/- S.E.M.) rose from 8 +/- 1 to 16 +/- 2 ng per milliliter--values identical to those observed in 12 other patients with poorly controlled diabetes (17 +/- 3 ng per milliliter). Plasma glucose concentrations doubled within 8 to 10 hours and remained elevated until growth hormone was discontinued (fasting glucose level rose from 86 +/- 11 to 204 +/- 17 mg per deciliter at 18 hours and to 240 +/- 20 mg per deciliter at 42 hours). The hyperglycemia was due mainly to a marked stimulation of hepatic glucose production that occurred without changes in levels of free insulin or glucagon. Levels of circulating free fatty acids, ketones, and branched-chain amino acids were also increased. The moderate elevations in growth hormone levels that occur in poorly controlled diabetes can themselves reproduce the whole spectrum of abnormal metabolic fuel concentrations that are associated with poor diabetic control, despite optimized insulin treatment. Thus, hypersecretion of growth hormone may be the cause as much as the consequence of poor diabetic control.

[1]  R L Hintz,et al.  Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. , 1981, The New England journal of medicine.

[2]  W. Tamborlane,et al.  Normalization of the Growth Hormone and Catecholamine Response to Exercise in Juvenile-Onset Diabetic Subjects Treated with a Portable Insulin Infusion Pump , 1979, Diabetes.

[3]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[4]  E. Tsalikian,et al.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. , 1976, The Journal of clinical investigation.

[5]  Wright Pd,et al.  The effect of surgical operation on growth hormone levels in plasma. , 1975 .

[6]  A. D. Goodman,et al.  Studies on "big" growth hormone from human plasma and pituitary. , 1974, The Journal of clinical investigation.

[7]  Fineberg Se,et al.  Acute Metabolic Effects of Human Growth Hormone , 1974 .

[8]  P. Felig,et al.  Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. , 1973, The Journal of clinical investigation.

[9]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[10]  W. F. Taylor,et al.  Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis. , 1972, The Journal of clinical endocrinology and metabolism.

[11]  K. Johansen,et al.  Diurnal Serum Growth Hormone Levels in Poorly and Well-controlled Juvenile Diabetics , 1971, Diabetes.

[12]  A. P. Hansen Abnormal serum growth hormone response to exercise in juvenile diabetics. , 1970, The Journal of clinical investigation.

[13]  T. Olsen,et al.  Diabetes, diabetic angiopathy, and growth hormone. , 1970, Lancet.

[14]  P. Cryer,et al.  Diabetic Ketosis: Serial Plasma Growth Hormone Concentrations During Therapy , 1970, Diabetes.

[15]  D. Mintz,et al.  Endogeneous Insulin and Growth Hormone Response in Children with Newly Diagnosed Diabetes Mellitus , 1968, Pediatric Research.

[16]  M. Novak COLORIMETRIC ULTRAMICRO METHOD FOR THE DETERMINATION OF FREE FATTY ACIDS. , 1965, Journal of lipid research.

[17]  R. Unger HIGH GROWTH-HORMONE LEVELS IN DIABETIC KETOACIDOSIS: A POSSIBLE CAUSE OF INSULIN RESISTANCE. , 1965, JAMA.

[18]  R. Luft,et al.  EFFECT OF HUMAN GROWTH HORMONE ON GLUCOSE TOLERANCE AND SOME INTERMEDIARY METABOLITES IN MAN , 1962 .

[19]  R. Fraser ENDOCRINE DISORDERS AND INSULIN ACTION , 1960 .

[20]  H. Olivecrona,et al.  The effect of human growth hormone in hypophysectomized human diabetic subjects. , 1959, Acta endocrinologica.

[21]  R. Steele,et al.  Effect of growth hormone on carbohydrate metabolism in normal and hypophysectomized dogs; studies with C14 glucose. , 1958, The American journal of physiology.

[22]  S. Moore,et al.  Automatic recording apparatus for use in the chromatography of amino acids. , 1958, Federation proceedings.

[23]  P. Bondy Growth Hormone in Humans * , 1954, The Yale journal of biology and medicine.

[24]  F. Young,et al.  Diabetogenic Action of Pure Anterior Pituitary Growth Hormone , 1949, Nature.

[25]  E. Froesch,et al.  Biological properties of NSILA-S. , 1975, Advances in metabolic disorders.

[26]  K. Zierler,et al.  EFFECT OF HUMAN GROWTH HORMONE ON MUSCLE AND ADIPOSE TISSUE METABOLISM IN THE FOREARM OF MAN. , 1965, The Journal of clinical investigation.

[27]  H. Krebs,et al.  Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in blood , 1962 .